Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/20/24 16:19 | 11/18/24 | PSNL | Health | Health | Medical Laboratories | Tachibana Aaron | CA | O | CFO,COO | 1 | S | -5 | 3.79 | 0 | -1 | 174 | D | |||||||||||||||
11/20/24 16:17 | 11/18/24 | PSNL | Health | Health | Medical Laboratories | Moore Stephen Michael | CA | O | SVP,GC | 1 | S | -6 | 3.79 | 0 | -2 | 67 | D | |||||||||||||||
11/20/24 16:14 | 11/18/24 | PSNL | Health | Health | Medical Laboratories | Chen Richard | CA | O | Chief Me | 1 | S | -3 | 3.79 | 0 | -1 | 129 | D | |||||||||||||||
11/5/24 16:15 | 11/1/24 | PSNL | Health | Health | Medical Laboratories | Hall Christopher M | CA | DO | P,CEO | 1 | S | -142 | 5.38 | 0 | -26 | 178 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |